Livermore's Purchase Of Japanese Supercomputer Is Blocked

Congress fears that the deal with the weapons lab would have allowed NEC Corp. to acquire U.S. software expertise A move by the U.S. Senate to give scientists at Lawrence Livermore National Laboratory the chance to buy and test a new Japanese supercomputer has been derailed by political fears that such purchases would hurt home-grown companies and contribute to the erosion of the nation's competitive edge. Language that would have given Livermore explicit permission to purchase a supercompute

Written byMarcia Clemmitt
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Language that would have given Livermore explicit permission to purchase a supercomputer from Tokyo-based NEC Corp. was adopted by a Senate panel and modified slightly by the full Senate as part of a 1991 funding bill that covers energy and water projects. The wording was watered down, however, in a conference agreement with the House of Representatives in the last few weeks before Congress adjourned last month. The final version gives the Energy Department, which funds the $1 billion-a-year nuclear weapons lab, permission to hold "an open competition" for a supercomputer at some unspecified time.

However, the debate is expected to continue into next year, when the world's leading supercomputer companies unveil the next generation of these multimillion-dollar machines. And it evokes memories of a similar attempt in 1987 by the Massachusetts Institute of Technology to buy an NEC supercomputer.

Officials at the Commerce and Defense departments, as well as ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies